Risk of Neurological Adverse Events during Tumour Necrosis FactorInhibitor Treatment for Arthritis:: A Population-Based Cohort Study from Danbio and the Danish National Patient Registry

Lene Dreyer; Tine Iskov Kopp; Rikke Kart Jacobsen; Melinda Magyari; Else Helene Ibfelt; Henning Locht; Finn Thorup Sellebjerg; Dorte Vendelbo Jensen; Rene Cordtz

doi:10.1002/art.40700

Risk of Neurological Adverse Events during Tumour Necrosis FactorInhibitor Treatment for Arthritis: A Population-Based Cohort Study from Danbio and the Danish National Patient Registry

Lene Dreyer, Tine Iskov Kopp, Rikke Kart Jacobsen, Melinda Magyari, Else Helene Ibfelt, Henning Locht, Finn Thorup Sellebjerg, Dorte Vendelbo Jensen, Rene Cordtz

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Abstract

Originalsprog	Engelsk
Tidsskrift	Arthritis & Rheumatology
Vol/bind	70
Udgave nummer	Suppl. 9
Sider (fra-til)	3329
ISSN	2326-5191
DOI	https://doi.org/10.1002/art.40700
Status	Udgivet - 1 sep. 2018
Begivenhed	The American College of Rheumatology, ACR/ARHP Annual Meeting - Chicago, IL, USA Varighed: 19 okt. 2018 → 24 okt. 2018

Konference

Konference	The American College of Rheumatology, ACR/ARHP Annual Meeting
Land/Område	USA
By	Chicago, IL
Periode	19/10/2018 → 24/10/2018

Bibliografisk note

Abstract no. 2955

Adgang til dokumentet

10.1002/art.40700

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Andre filer og links

http://www.scopus.com/inward/record.url?scp=85055074367&partnerID=8YFLogxK

Citationsformater

Dreyer, L., Kopp, T. I., Jacobsen, R. K., Magyari, M., Ibfelt, E. H., Locht, H., Sellebjerg, F. T., Jensen, D. V., & Cordtz, R. (2018). Risk of Neurological Adverse Events during Tumour Necrosis FactorInhibitor Treatment for Arthritis: A Population-Based Cohort Study from Danbio and the Danish National Patient Registry. Arthritis & Rheumatology, 70(Suppl. 9), 3329. https://doi.org/10.1002/art.40700

@article{7e2cf6bb032947cdb6f5e6126c9dc324,

title = "Risk of Neurological Adverse Events during Tumour Necrosis FactorInhibitor Treatment for Arthritis:: A Population-Based Cohort Study from Danbio and the Danish National Patient Registry",

author = "Lene Dreyer and Kopp, {Tine Iskov} and Jacobsen, {Rikke Kart} and Melinda Magyari and Ibfelt, {Else Helene} and Henning Locht and Sellebjerg, {Finn Thorup} and Jensen, {Dorte Vendelbo} and Rene Cordtz",

note = "Abstract no. 2955; The American College of Rheumatology, ACR/ARHP Annual Meeting ; Conference date: 19-10-2018 Through 24-10-2018",

year = "2018",

month = sep,

day = "1",

doi = "10.1002/art.40700",

language = "English",

volume = "70",

pages = "3329",

journal = "Arthritis & Rheumatology",

issn = "2326-5191",

publisher = "Wiley",

number = "Suppl. 9",

}

Dreyer, L, Kopp, TI, Jacobsen, RK, Magyari, M, Ibfelt, EH, Locht, H, Sellebjerg, FT, Jensen, DV & Cordtz, R 2018, 'Risk of Neurological Adverse Events during Tumour Necrosis FactorInhibitor Treatment for Arthritis: A Population-Based Cohort Study from Danbio and the Danish National Patient Registry', Arthritis & Rheumatology, bind 70, nr. Suppl. 9, s. 3329. https://doi.org/10.1002/art.40700

Risk of Neurological Adverse Events during Tumour Necrosis FactorInhibitor Treatment for Arthritis: A Population-Based Cohort Study from Danbio and the Danish National Patient Registry. / Dreyer, Lene; Kopp, Tine Iskov; Jacobsen, Rikke Kart et al.
I: Arthritis & Rheumatology, Bind 70, Nr. Suppl. 9, 01.09.2018, s. 3329.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

TY - JOUR

T1 - Risk of Neurological Adverse Events during Tumour Necrosis FactorInhibitor Treatment for Arthritis:

T2 - The American College of Rheumatology, ACR/ARHP Annual Meeting

AU - Dreyer, Lene

AU - Kopp, Tine Iskov

AU - Jacobsen, Rikke Kart

AU - Magyari, Melinda

AU - Ibfelt, Else Helene

AU - Locht, Henning

AU - Sellebjerg, Finn Thorup

AU - Jensen, Dorte Vendelbo

AU - Cordtz, Rene

N1 - Abstract no. 2955

PY - 2018/9/1

Y1 - 2018/9/1

UR - http://www.scopus.com/inward/record.url?scp=85055074367&partnerID=8YFLogxK

U2 - 10.1002/art.40700

DO - 10.1002/art.40700

M3 - Journal article

SN - 2326-5191

VL - 70

SP - 3329

JO - Arthritis & Rheumatology

JF - Arthritis & Rheumatology

IS - Suppl. 9

Y2 - 19 October 2018 through 24 October 2018

ER -